Scaling Tumor Segmentation: Best Lessons from Real and Synthetic Data
By: Qi Chen , Xinze Zhou , Chen Liu and more
Potential Business Impact:
Makes AI find tumors with less real scans.
AI for tumor segmentation is limited by the lack of large, voxel-wise annotated datasets, which are hard to create and require medical experts. In our proprietary JHH dataset of 3,000 annotated pancreatic tumor scans, we found that AI performance stopped improving after 1,500 scans. With synthetic data, we reached the same performance using only 500 real scans. This finding suggests that synthetic data can steepen data scaling laws, enabling more efficient model training than real data alone. Motivated by these lessons, we created AbdomenAtlas 2.0--a dataset of 10,135 CT scans with a total of 15,130 tumor instances per-voxel manually annotated in six organs (pancreas, liver, kidney, colon, esophagus, and uterus) and 5,893 control scans. Annotated by 23 expert radiologists, it is several orders of magnitude larger than existing public tumor datasets. While we continue expanding the dataset, the current version of AbdomenAtlas 2.0 already provides a strong foundation--based on lessons from the JHH dataset--for training AI to segment tumors in six organs. It achieves notable improvements over public datasets, with a +7% DSC gain on in-distribution tests and +16% on out-of-distribution tests.
Similar Papers
Assessment of Using Synthetic Data in Brain Tumor Segmentation
CV and Pattern Recognition
Makes AI better at finding brain tumors in scans.
Lightweight MRI-Based Automated Segmentation of Pancreatic Cancer with Auto3DSeg
CV and Pattern Recognition
Helps doctors find tumors in body scans.
State of Abdominal CT Datasets: A Critical Review of Bias, Clinical Relevance, and Real-world Applicability
Image and Video Processing
Makes AI better at reading body scans.